Home › Therapeutic areas › Neurology › Angelman Syndrome
Angelman Syndrome (1 companies)
Companies with an active program in Angelman Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| IONS | Ionis Pharmaceuticals | CardiovascularHematology+5 Rare | 1 | Approved | $6.55B | 29 |
No companies match.